Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion.
about
Mycobacterium tuberculosis infection of human dendritic cells decreases integrin expression, adhesion and migration to chemokinesThe involvement of IL-17A in the murine response to sub-lethal inhalational infection with Francisella tularensisIntranasal immunization with an archaeal lipid mucosal vaccine adjuvant and delivery formulation protects against a respiratory pathogen challengeOuter membrane vesicles displaying engineered glycotopes elicit protective antibodiesMonophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity.Novel catanionic surfactant vesicle vaccines protect against Francisella tularensis LVS and confer significant partial protection against F. tularensis Schu S4 strainRationally designed tularemia vaccines.Francisella tularensis T-cell antigen identification using humanized HLA-DR4 transgenic mice.Glycosylation of a Capsule-Like Complex (CLC) by Francisella novicida Is Required for Virulence and Partial Protective Immunity in Mice.Detoxified endotoxin vaccine (J5dLPS/OMP) protects mice against lethal respiratory challenge with Francisella tularensis SchuS4.IFN-γ, but not IL-17A, is required for survival during secondary pulmonary Francisella tularensis Live Vaccine Stain infectionA broadly applicable approach to T cell epitope identification: application to improving tumor associated epitopes and identifying epitopes in complex pathogens.A Francisella tularensis live vaccine strain (LVS) mutant with a deletion in capB, encoding a putative capsular biosynthesis protein, is significantly more attenuated than LVS yet induces potent protective immunity in mice against F. tularensis chalHost-pathogen interactions and immune evasion strategies in Francisella tularensis pathogenicityMucosal immunization with live attenuated Francisella novicida U112ΔiglB protects against pulmonary F. tularensis SCHU S4 in the Fischer 344 rat modelA mucosal subunit vaccine protects against lethal respiratory infection with Francisella tularensis LVS.IKKβ in myeloid cells controls the host response to lethal and sublethal Francisella tularensis LVS infection.Antibodies contribute to effective vaccination against respiratory infection by type A Francisella tularensis strainsThe capBCA Locus is Required for Intracellular Growth of Francisella tularensis LVS.Vaccines against tularemia.Innate endogenous adjuvants prime to desirable immune responses via mucosal routesPreclinical testing of a vaccine candidate against tularemia.Intranasal administration of an inactivated Yersinia pestis vaccine with interleukin-12 generates protective immunity against pneumonic plagueDownmodulation of vaccine-induced immunity and protection against the intracellular bacterium Francisella tularensis by the inhibitory receptor FcγRIIB.Development of a Multivalent Subunit Vaccine against Tularemia Using Tobacco Mosaic Virus (TMV) Based Delivery System.Identification of a novel Francisella tularensis factor required for intramacrophage survival and subversion of innate immune response.Identification of Francisella tularensis outer membrane protein A (FopA) as a protective antigen for tularemia.Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs.Native outer membrane proteins protect mice against pulmonary challenge with virulent type A Francisella tularensis.Neisseria meningitidis PorB, a Toll-like receptor 2 ligand, improves the capacity of Francisella tularensis lipopolysaccharide to protect mice against experimental tularemia.Tularemia vaccine development: paralysis or progress?Mucosal vaccines: novel strategies and applications for the control of pathogens and tumors at mucosal sites.An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain.Increased susceptibility of IgA-deficient mice to pulmonary Francisella tularensis live vaccine strain infectionRecombinant attenuated Listeria monocytogenes vaccine expressing Francisella tularensis IglC induces protection in mice against aerosolized Type A F. tularensis.Oral live vaccine strain-induced protective immunity against pulmonary Francisella tularensis challenge is mediated by CD4+ T cells and antibodies, including immunoglobulin A.An improved Francisella tularensis live vaccine strain (LVS) is well tolerated and highly immunogenic when administered to rabbits in escalating doses using various immunization routes.Utilization of Fc receptors as a mucosal vaccine strategy against an intracellular bacterium, Francisella tularensis.Identification of a dominant CD4 T cell epitope in the membrane lipoprotein Tul4 from Francisella tularensis LVS.Enhancement of adaptive immunity to Neisseria gonorrhoeae by local intravaginal administration of microencapsulated interleukin 12.
P2860
Q24319894-6D8BC0EF-1F71-4008-B5D0-F19B92A2DBBBQ27324829-3B59B244-BBD8-4E5F-B9D3-BC31BC82E51DQ28743895-E4571467-2113-4CA6-BD57-CF2AECA116FAQ28831290-D565688D-2119-4FD2-A1B4-96621CC68F58Q30275022-BDE777DE-B04E-4179-8EC8-FD37F127C117Q30411506-D4EFB7E9-5242-4269-985A-ACF078F59C7CQ30436251-83B1E130-7303-44EB-8F18-691226822EBEQ33627084-52DC7DE2-537A-418B-AB08-050C2CE8EDC6Q33736711-98FB9923-3DA8-448B-BCC9-10C4324A9E1CQ33759497-827A32AD-A5A4-4675-8BA6-60B3ED3968C9Q33822265-7832F043-0E4C-4190-857A-0B7F29F16BA8Q34004266-4675A1CA-E8D0-430B-996A-2E6E98967982Q34177350-AA0B399A-936D-4E14-A483-FFA0BFA9D5BAQ34237666-4BD077F1-D889-4F98-8734-F56FCDC7F679Q34464553-4C608788-EA11-4EDD-9689-35AD6B7F6DFBQ34500312-C78F0655-C5DF-4C17-92FF-E6F2B905314EQ34562654-CE0838D8-5600-4AC8-9ED2-E5F4CEC902C0Q34740339-80374E24-9390-4461-804A-041F7CD85D0BQ35084495-93409434-6012-4EEE-99F6-87F4B326FF6CQ35095362-F0464258-31A9-403C-8705-25E1D81391BCQ35143128-FFFB2D59-9387-4E79-8642-4EC2231606A1Q35513176-B5DEA7FB-2EDA-46F9-A610-961986413915Q35530270-FC7727AF-ECB6-4D8F-9564-FF405C7E0575Q35563406-2D4C9893-C7E1-4FA9-8B5E-D7B1E21E500DQ35670540-135FB363-D816-4BE3-8D5A-BE78D4119B3DQ36127190-BEA954B2-A154-413C-A849-1E858A9E9F13Q36191199-24BD67EC-BC2A-48E0-A997-E0170B56B75AQ36446956-CF3C09BE-A3E4-485B-9E75-A4E8A06CB094Q36804275-359A015E-8A3C-4ED9-B4D0-B9EFB3ACE21DQ36898076-D837B3BE-6FA7-4B21-AEE1-39D5CA239FEFQ36908692-CA058C0A-86DB-4828-945E-5BDA88FE4F9BQ36978334-F7D54B06-29CF-4C8C-9E0E-5DC206B6FBD5Q37120769-EAC97C10-CB2C-447B-BF6A-46E7BE8926A3Q37123754-6B41F897-C19A-4B17-A11C-7D486DDCAF40Q37125549-7CDBE979-2C2C-46F6-8BA4-90512C4F8421Q37156774-2C0A208C-3392-4615-A37C-4E5901ABD566Q37183341-CE7A72C8-1779-448F-9761-17170E68038FQ37209029-78520FE7-22F2-46E5-BF94-2F20E257C13EQ37258244-8E0964D5-68CC-4DCF-B7EA-B958114676BAQ37272314-1999EE5F-B68F-4A68-A8BC-DBCF97B63131
P2860
Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Inactivated Francisella tulare ...... oglobulin A-dependent fashion.
@ast
Inactivated Francisella tulare ...... oglobulin A-dependent fashion.
@en
type
label
Inactivated Francisella tulare ...... oglobulin A-dependent fashion.
@ast
Inactivated Francisella tulare ...... oglobulin A-dependent fashion.
@en
prefLabel
Inactivated Francisella tulare ...... oglobulin A-dependent fashion.
@ast
Inactivated Francisella tulare ...... oglobulin A-dependent fashion.
@en
P2860
P356
P1476
Inactivated Francisella tulare ...... noglobulin A-dependent fashion
@en
P2093
Rajendra Singh
Shawn D Baron
P2860
P304
P356
10.1128/IAI.01606-06
P407
P577
2007-02-12T00:00:00Z